The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The incidence and implications of aldosterone breakthrough
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040135 · Cited by 1,761
Aldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
McKelvie, R. S., Yusuf, S., Pericak, D., Avezum, A., Burns, R. J., Probstfield, J., Tsuyuki, R. T., White, M., Rouleau, J., Latini, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.10.1056 · Cited by 692
Control of aldosterone secretion: a model for convergence in cellular signaling pathways
SPÄT, A., & HUNYADY, L. (2004) · Physiological Reviews · doi:10.1152/physrev.00030.2003 · Cited by 494
Role of aldosterone in the remnant kidney model in the rat.
Greene, E. L., Kren, S., & Hostetter, T. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118867 · Cited by 479
Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
Rocha, R. (2000) · Endocrinology · doi:10.1210/en.141.10.3871 · Cited by 475
Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
Sato, A., Hayashi, K., Naruse, M., & Saruta, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000044937.95080.e9 · Cited by 466
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Epstein, M., Williams, G. H., Weinberger, M., Lewin, A., Krause, S., Mukherjee, R., Patni, R., & Beckerman, B. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240106 · Cited by 459
Nussberger, J., Wuerzner, G., Jensen, C., & Brunner, H. R. (2002) · Hypertension · doi:10.1161/hy0102.102293 · Cited by 409
Crowley, S. D., Gurley, S. B., Oliverio, M. I., Pazmino, A. K., Griffiths, R., Flannery, P. J., Spurney, R. F., Kim, H.-S., Smithies, O., Le, T. H., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23378 · Cited by 351
Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
STAESSEN, J., LIJNEN, P., FAGARD, R., VERSCHUEREN, L. J., & AMERY, A. (1981) · Journal of Endocrinology · doi:10.1677/joe.0.0910457 · Cited by 339
Bianchi, S., Bigazzi, R., & Campese, V. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001854 · Cited by 338
Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Zuckerman, A., & Stier, C. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.232 · Cited by 310
Aldosterone in the development and progression of renal injury
Hollenberg, N. K. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00701.x · Cited by 273
Schjoedt, K. J., Andersen, S., Rossing, P., Tarnow, L., & Parving, H.-H. (2004) · Diabetologia · doi:10.1007/s00125-004-1542-0 · Cited by 249
Biollaz, J., Brunner, H. R., Gavras, I., Waeber, B., & Gavras, H. (1982) · PubMed · Cited by 238
Azizi, M., Ménard, J., Bissery, A., Guyenne, T.-T., Bura-Rivière, A., Vaidyanathan, S., & Camisasca, R. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000146686.35541.29 · Cited by 234
Chrysostomou, A., Pedagogos, E., MacGregor, L., & Becker, G. J. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01040905 · Cited by 211
Pitt, B. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877755 · Cited by 205
MacFadyen, R. J., Lee, A. F. C., Morton, J. J., Pringle, S. D., & Struthers, A. D. (1999) · Heart · doi:10.1136/hrt.82.1.57 · Cited by 205
Biollaz, J., Brunner, H. R., Gavras, I., Waeber, B., & Gavras, H. (1982) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198211000-00014 · Cited by 191
van den Meiracker, A. H., Baggen, R. G., Pauli, S., Lindemans, A., Vulto, A. G., Poldermans, D., & Boomsma, F. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000249708.44016.5c · Cited by 187
Sato, A., & Saruta, T. (2001) · Journal of International Medical Research · doi:10.1177/147323000102900103 · Cited by 148
Borghi, C., Boschi, S., Ambrosioni, E., Melandri, G., Branzi, A., & Magnani, B. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03901.x · Cited by 140
Cicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Cabrini, G., Bonizzato, A., Graziani, M., Anker, S. D., Coats, A. J. S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01237-2 · Cited by 137
The Clinical Implications of Aldosterone Escape in Congestive Heart Failure
Struthers, A. D. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.04.013 · Cited by 128
Aldosterone Blockade: An Emerging Strategy for Abrogating Progressive Renal Disease
Epstein, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.038 · Cited by 112
Aldosterone and cardiac fibrosis: in vitro studies
Fullerton, M., & Funder, J. W. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.12.1863 · Cited by 107
Tang, W. H. W., Vagelos, R. H., Yee, Y., Benedict, C. R., Willson, K., Liss, C. L., LaBelle, P., & Fowler, M. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01714-4 · Cited by 98
Cicoira, M., Zanolla, L., Franceschini, L., Rossi, A., Golia, G., Zeni, P., Caruso, B., & Zardini, P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02261-5 · Cited by 82
Athyros, V. G., Mikhailidis, D. P., Kakafika, A. I., Τζιόμαλος, Κ., & Karagiannis, A. I. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.5.529 · Cited by 80
Pouleur, H. G., Rousseau, M. F., van Eyll, C., Stoleru, L., Hayashida, W., Udelson, J. E., Dolan, N., Kinan, D., Gallagher, P., & Ahn, S. A. (1993) · Circulation · doi:10.1161/01.cir.88.2.481 · Cited by 80
Horita, Y., Taura, K., Taguchi, T., Furusu, A., & Kohno, S. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00665.x · Cited by 75
Aldosterone Antagonism in Chronic Kidney Disease
Ponda, M. P., & Hostetter, T. H. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00120106 · Cited by 75
Lee, A. F. C., MacFadyen, R. J., & Struthers, A. D. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00046-x · Cited by 72
Mineralocorticoid Receptors and Cardiovascular Damage
Funder, J. W. (2006) · Hypertension · doi:10.1161/01.hyp.0000203732.03784.3b · Cited by 41
The Role of the Glucocorticoid Receptor in Mineralocorticoid/Salt-Mediated Cardiac Fibrosis
Rickard, A. J., Funder, J. W., Fuller, P. J., & Young, M. J. (2006) · Endocrinology · doi:10.1210/en.2006-0658 · Cited by 37
Matos, J. P. S., Rodrigues, M., Ismerim, V. L., Boasquevisque, E. M., Genelhu, V. A., & Francischetti, E. A. (2005) · Clinical Nephrology · doi:10.5414/cnp64180 · Cited by 32
Rump, L. C. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl549 · Cited by 25
"Aldosterone escape" or refractory hyperaldosteronism?
Prakash, E. S. (2005) · PubMed · Cited by 7
Rousseau, M. F., Robert, A. R., Ketelslegers, J. M., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)80762-8 · Cited by 2
Cited by
Strict Blood-Pressure Control and Progression of Renal Failure in Children
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902066 · Cited by 956
Edelmann, F., Wachter, R., Schmidt, A. G., Kraigher-Krainer, E., Colantonio, C., Kamke, W., Duvinage, A., Stahrenberg, R., Durstewitz, K., Löffler, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.905 · Cited by 746
Neurohormonal activation in heart failure with reduced ejection fraction
Hartupee, J., & Mann, D. L. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.163 · Cited by 709
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Tuttle, K. R., Agarwal, R., Alpers, C. E., Bakris, G. L., Brosius, F. C., Kolkhof, P., & Uribarri, J. (2022) · Kidney International · doi:10.1016/j.kint.2022.05.012 · Cited by 668
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Agarwal, R., Kolkhof, P., Bakris, G., Bauersachs, J., Haller, H., Wada, T., & Zannad, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa736 · Cited by 638
Metadata
- Authors
- Bomback, A. S., & Klemmer, P. J.
- Venue
- Nature Clinical Practice Nephrology
- Published
- 2007-09
- Volume
- 3
- Issue
- 9
- Pages
- 486-492
- ISSN
- 1745-8323 (ISSN-L)
- 1745-8331
- OpenAlex
- W2010799694
- Cited by
- 420
- References
- 43
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.